Gabriele Schuhmann-Giampiere

Title: Gabriele Schuhmann-Giampiere: Innovator in Pharmaceutical Chemistry

Introduction

Gabriele Schuhmann-Giampiere is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing new compounds that have important applications in medical diagnostics and treatment.

Latest Patents

Gabriele's latest patents include "Multiply substituted DTPA derivatives and their metal complexes" and "Use of tetra azacycle complexes as x-ray diagnostic agents for the liver." The first patent relates to new, multiply substituted diethylenetriaminepentaacetic acid derivatives, their complexes, and complex salts. These compounds contain elements with atomic numbers ranging from 20-32, 39-51, or 57-83. They are designed for use as pharmaceutical agents, particularly as contrast media and antidotes. The second patent discloses metal complexes that are suitable as contrast media for computer tomography of the liver and biliary tracts.

Career Highlights

Gabriele Schuhmann-Giampiere is currently associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing the development of diagnostic agents that enhance imaging techniques in medical settings.

Collaborations

Throughout his career, Gabriele has collaborated with esteemed colleagues such as Franz-Karl Maier and Michael Bauer. These partnerships have contributed to the successful development of his innovative patents.

Conclusion

Gabriele Schuhmann-Giampiere stands out as a significant figure in pharmaceutical innovation. His contributions through patents not only advance medical technology but also enhance patient care through improved diagnostic methods.